VAC85135
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VAC85135, covering 2025-07-20 to 2025-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms [Phase 1]